Flagship VentureLabs IV, LLC
Insider CIK 1642578 · SYRS 10% owner · MCRB 10% owner · AXLA 10% owner · MRNA 10% owner · EVLO 10% owner · RUBY 10% owner · KLDO 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 895,255 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 89,525 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 358,102 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 151,643 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 617,914 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 222,506 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,005,413 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 1,384,615 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 4,153,847 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 928,074 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 386,697 | — | $0 | 0 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 751,691 | — | $0 | 1,430,301 | SEC↗ |
| AXLA Axcella Health Inc. | P Buy | 2019-05-13 | 2019-05-15 | 500,000 | $20.00 | $10.00M | 986,023 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 486,023 | — | $0 | 486,023 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 48,602 | — | $0 | 676,752 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 194,409 | — | $0 | 3,288,780 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 82,324 | — | $0 | 628,150 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 335,457 | — | $0 | 3,094,371 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 120,795 | — | $0 | 1,761,029 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 2,255,074 | — | $0 | 2,255,074 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 503,840 | — | $0 | 2,758,914 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 209,933 | — | $0 | 1,640,234 | SEC↗ |
| AXLA Axcella Health Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 545,826 | — | $0 | 545,826 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 347,173 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 1,331,816 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion deriv | 2019-03-04 | 2019-03-06 | 562,407 | — | $0 | 0 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 665,908 | — | $0 | 665,908 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 173,586 | — | $0 | 216,451 | SEC↗ |
| KLDO Kaleido Biosciences, Inc. | C Conversion | 2019-03-04 | 2019-03-06 | 281,203 | — | $0 | 947,111 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 1,428,432 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 5,713,739 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 6,195,632 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 24,782,551 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 1,823,036 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 7,292,145 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 21,496 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion deriv | 2018-12-11 | 2018-12-13 | 85,989 | — | $0 | 0 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 6,195,632 | — | $0 | 8,018,668 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 24,782,551 | — | $0 | 32,074,696 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 5,713,739 | — | $0 | 37,788,435 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 1,428,432 | — | $0 | 9,447,100 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 7,292,145 | — | $0 | 7,292,145 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 1,823,036 | — | $0 | 1,823,036 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 21,496 | — | $0 | 9,468,596 | SEC↗ |
| MRNA Moderna, Inc. | C Conversion | 2018-12-11 | 2018-12-13 | 85,989 | — | $0 | 37,874,424 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion deriv | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 0 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 3,830,402 | — | $0 | 3,830,402 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 15,323,593 | — | $0 | 15,323,593 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 781,860 | — | $0 | 2,563,703 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 195,466 | — | $0 | 5,789,414 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 1,781,843 | — | $0 | 1,781,843 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 593,948 | — | $0 | 5,593,948 | SEC↗ |
| RUBY Rubius Therapeutics, Inc. | C Conversion | 2018-07-20 | 2018-07-23 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 4,643,963 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 18,611,110 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 8,333,000 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 5,416,667 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 10,102,055 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion deriv | 2018-05-11 | 2018-05-15 | 12,536,945 | — | $0 | 0 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | P Buy | 2018-05-11 | 2018-05-15 | 281,250 | $16.00 | $4.50M | 18,233,403 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | C Conversion | 2018-05-11 | 2018-05-15 | 14,622,143 | — | $0 | 17,952,153 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | J Other | 2017-08-17 | 2017-08-21 | 1,295,997 | — | $0 | 2,378,663 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | J Other | 2017-08-17 | 2017-08-21 | 306,222 | — | $0 | 612,442 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | J Other | 2017-08-17 | 2017-08-21 | 54,293 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 800,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 6,000,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 1,500,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 1,779,981 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 444,995 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 200,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 4,000,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion deriv | 2016-07-06 | 2016-07-07 | 1,000,000 | — | $0 | 0 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 53,333 | — | $0 | 53,333 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 474,661 | — | $0 | 3,354,660 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-07 | 320,000 | $12.50 | $4.00M | 3,674,660 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | P Buy | 2016-07-06 | 2016-07-07 | 80,000 | $12.50 | $1.00M | 918,664 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 213,333 | — | $0 | 213,333 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 118,665 | — | $0 | 838,664 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 1,066,666 | — | $0 | 1,279,999 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 266,666 | — | $0 | 319,999 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 1,600,000 | — | $0 | 2,879,999 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | C Conversion | 2016-07-06 | 2016-07-07 | 400,000 | — | $0 | 719,999 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 800,000 | — | $0 | 8,022,420 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 599,297 | $27.60 | $16.54M | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 80,141 | $27.60 | $2.21M | 1,925,462 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | S Sale | 2016-05-25 | 2016-05-27 | 320,562 | $27.60 | $8.85M | 2,734,994 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 33,514 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 7 | — | $0 | 33,514 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 33,507 | — | $0 | 33,514 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | J Other | 2016-05-25 | 2016-05-27 | 200,000 | — | $0 | 1,925,462 | SEC↗ |